

Over the past 12 months, $SGMO has been discussed by 2 distinct FinTwit voices, with 18 total mentions recorded between September 11, 2025 and June 23, 2026. Adam Feuerstein (@adamfeuerstein) dominated discussion of Sangamo Therapeutics with 17 mentions, while InvestmentGuru (@investmentguru_) contributed 1 mention. The biotech sector voice category was most active for this ticker during the tracking period.
The most recent discussion of $SGMO from June 2026 indicated that the company ended with a bankruptcy sale of its assets, with Lilly and Astellas identified as stalking horse bidders. Prior posts from late April 2026 suggested negative sentiment regarding the stock's trajectory during that period.
@adamfeuerstein (Adam Feuerstein ✡️) mentions $SGMO most — 17 mentions in the past 12 months.
The earliest tracked mention of $SGMO in the Surfaced archive was on Sep 11, 2025.
2 FinTwit voices have mentioned $SGMO 18 times in the past 12 months.
$SGMO is mentioned most by Biotech voices on Surfaced.
